Verano Holdings (VRNO) Current Assets (2021 - 2026)

Verano Holdings' (VRNO) quarterly Current Assets came in at $394.5 million in Q1 2026, up 9.24% year-on-year from $361.1 million in Q1 2025, and down 2.5% on a QoQ basis from $404.7 million in Q4 2025.

Verano Holdings (VRNO) Current Assets (2021 - 2026) Analysis & Trends

Verano Holdings (VRNO) has 6 years of Current Assets data on file, last reported at $394.5 million in Q1 2026.

  • On a quarterly basis, Current Assets rose 9.24% year-over-year to $394.5 million in Q1 2026; TTM through Mar 2026 was $394.5 million, a 9.24% increase from a year earlier, with the FY2025 full-year figure at $404.7 million, up 11.58% from the prior year.
  • Current Assets for Q1 2026 stood at $394.5 million, down from $404.7 million in the prior quarter.
  • Over the last five years, Current Assets for VRNO reached as high as $418.8 million in Q1 2024 and fell as low as $288.0 million in Q2 2022.
  • Historically, Current Assets has averaged $353.9 million across 5 years, with a median of $359.4 million in 2024.
  • Across the five-year window, Current Assets surged 32.63% in 2024 and fell 13.76% in 2025, its largest moves.
  • Year by year, Current Assets stood at $318.3 million in 2022, then climbed by 23.85% to $394.2 million in 2023, then dropped by 8.0% to $362.7 million in 2024, then gained by 11.58% to $404.7 million in 2025, then fell by 2.5% to $394.5 million in 2026.
  • Per Business Quant data, the three most recent Current Assets figures were $394.5 million in Q1 2026, $404.7 million in Q4 2025, and $385.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 6.05 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 13.71 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 6.47 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 19.71 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 2.87 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 53.60 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 10.92 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 2.44 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 3.58 Bn
10 Verano Holdings 2.02 Bn 1.94 Bn 98.98 Mn 394.52 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 394.52 Mn
Dec 31, 2025 404.65 Mn
Sep 30, 2025 385.43 Mn
Jun 30, 2025 371.36 Mn
Mar 31, 2025 361.14 Mn
Dec 31, 2024 362.65 Mn
Sep 30, 2024 321.72 Mn
Jun 30, 2024 357.56 Mn
Mar 31, 2024 418.78 Mn
Dec 31, 2023 394.20 Mn
Sep 30, 2023 355.00 Mn
Jun 30, 2023 318.93 Mn
Mar 31, 2023 315.76 Mn
Dec 31, 2022 318.28 Mn
Sep 30, 2022 295.07 Mn
Jun 30, 2022 287.96 Mn
Dec 31, 2021 277.04 Mn